Morphofunctional Peculiarities of Platelet Rich Plasma and Its Application in Ophthalmology
https://doi.org/10.18008/1816-5095-2018-4-388-393
Abstract
This article is dedicated to the realistic, present-day problem in treating patients with a damaged cornea. It contains a general summary of the practical experience of treatments in various spheres of medicine and in ophthalmology in particular, concerning the new developing method of restoring tissue with the aid of platelet rich plasma. This is a branch of regenerative medicine. In ophthalmology an effective method has long been sought for treating patients with a damaged cornea. It is well-known that platelet rich plasma contains a high quantity of elements which contribute to growth: thrombocyte, transformation, insulin-like, epidermal etc. And although the mechanism of the parts their role has not been sufficiently studied, the positive results of the PRP use in various fields of surgical medicine and in particular in the treatment of burns and ulcers of the tissue, speak of the key role being played in the growth factor and the process of tissue restoration. Despite the fact that this method has not been fully studied by ophthalmologists, it is of great interest to practising doctors, considering its potential value due to it being therapeutically effective and both simple and economic to produce. Our aim here is to give a short overview of the literature which contains descriptions of the morphological qualities of thrombocytes, to note and describe the characteristics of PRP and its role in the regeneration of tissue, to make special note of the history of the discovery of the growth factor in medico-biological science and to analyze the publications which give details of the PRP use.
About the Authors
E. V. Fedoseeva
Moscow Helmholtz’s Research Institute of Eye Diseases
Russian Federation
Russian Federation
ophtalmologist
Sadovaya-Chernogryazskaya str., 14/19, Moscow, 105062, Russia
E. V. Chentsova
Moscow Helmholtz’s Research Institute of Eye Diseases
Russian Federation
Russian Federation
MD, professor
Sadovaya-Chernogryazskaya str., 14/19, Moscow, 105062, Russia
N. V. Borovkova
N.V. Sklifosovsky Research Institute for Emergency Medicine
Russian Federation
Russian Federation
MD
Bolshaya Sukharevskaya sq., 3, bldng 21, Moscow, 129090, Russia
I. B. Alekseeva
Moscow Helmholtz’s Research Institute of Eye Diseases
Russian Federation
Russian Federation
PhD, ophthalmologist
Sadovaya-Chernogryazskaya str., 14/19, Moscow, 105062, Russia
I. Yu. Romanova
Moscow Helmholtz’s Research Institute of Eye Diseases
Russian Federation
Russian Federation
PhD, ophthalmologist
Sadovaya-Chernogryazskaya str., 14/19, Moscow, 105062, Russia
References
1. Егорова Н.С., Ченцова Е.В., Боровкова Н.В., Макаров М.С., Сторожева М.В. Репаративный эффект биоконструкции на основе коллагена I типа и клеток буккального эпителия при лечении глубоких дефектов роговицы в эксперименте. Трансплантология. 2017;9(3):226–235 [Egorova N.S., Chentsova E.V., Borovkova N.V, Makarov M.S., Storozheva M.V. Reparative effect of bioconstruction based on collagen I type and buccal epithelium cells in the treatment of deep corneal defects in the experiment. Transplantology = Transplantologiya. 2017;9(3):226–235 (In Russ.)]. DOI: 10.23873/2074-0506-2017-9-3-226-235
2. Anitua E. The use of plasma-rich growth factors (PRGF) in oral surgery. Pract Proced Aesthet Dent. 2001;13(6):487–493.
3. Foster T.E., Puskas B.L., Mandelbaum B.R., Gerhardt M.B., Rodeo S.A. Plateletrich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259–2272.
4. Foster T.E., Puskas B.L., Mandelbaum B.R., Gerhardt M.B., Rodeo S.A. Plateletrich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259–2272.
5. Intini G. The use of platelet-rich plasma in bone reconstruction therapy. Biomaterials. 2009;30(28):4956–4966.
6. Anitua E., Orive G., Pla R., Roman P., Serrano V., Andia I. The effects of PRGF on bone regeneration and on titanium implant osseointegration in goats: a histologic and histomorphometric study. Biomed Mater Res A. 2009;91(1):158–165. DOI: 10,1002/jbm.a.32217
7. Garg A.K., Gargenese D., Pease I. Using platelet-rich plasma to develop an autologous membrane for growth factor delivery in dental implant therapy. Dent Implantol Update. 2000;11(6):41–44.
8. Sanchez M., Anitua E., Azofra E., Aguirre J., Andia I. Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheutamol. 2008;26(5):910–913.
9. Оболенский В.Н., Ермолова Д.А. Применение тромбоцитарных факторов роста и коллагеновых биопрепаратов в лечении больных с хроническими трофическими язвами различной этиологии. Хирургия. Журнал им. Н.И. Пирогова. 2012;(5):42–47 [Obolensky V.N., Ermolova D.A. Use of Platelet Enriched Plasma and Collagen-Containing Biopreparations in the Treatment of Patients with Chronic Wounds of Different Etiologies. Surgery. Journal named N.I. Pirogov = Khirurgiya. Zhurnal imeni N.I. Pirogova. 2012;(5):42–47 (In Russ.)].
10. Nurden A.T., Nurden P., Sanchez M., Andia I., Anitua E. Platelets and wound healing. Front Biosci. 2008;13:3532–3548.
11. Костюкович Н.Н. Первооткрыватель факторов роста и Нобелевский лауреат Стэнли Коэн. Вестник фонда фундаментальных исследований. 2011;4:112–144 [Kostyukovich N.N. Pioneer of growth factors and Nobel Prize winner Stanley Cohen. Bulletin of the Foundation for Fundamental Research = Vestnik fonda fundamental’nyh issledovanij. 2011;4:112–144 (In Russ.)].
12. Пантелеев М.А., Свешникова А.Н. Тромбоциты и гемостаз. Онкогематология. 2014;2:65–73 [Panteleev M.A., Sveshnikova A.N. Platelets and hemostasis. Oncohematology = Onkogematologiya. 2014;2:65–73 (In Russ.)]. DOI: 10.17650/1818-8346-2014-9-2-65-73
13. Martin J.F. A role for changes in platelet production in the cause of acute coronary syndromes. Arterioscler Thromb Vasc Biol. 1999;19:672–679.
14. Макаров М.С., Кобзева Е.Н., Высочин И.В., Боровкова Н.В., Хватов В.Б. Морфофункциональный анализ тромбоцитов человека с помощью витального окрашивания. Бюллетень экспериментальной биологии и медицины. 2013;156(9):391 [Makarov M.S., Kobzeva E.N., Vysochin I.V., Borovkova N.V., Khvatov V.B. Morphofunctional analysis of human platelets with the help of vital staining. Bulletin of Experimental Biology and Medicine = Byulleten’ ehksperimental’noj biologii i mediciny. 2013;156(9):391 (In Russ.)].
15. Reed G.L. Platelet secretion. In: Michelson A.D. (ed.) Platelets. San Diego, CA: Academic, 2002. P. 181–195.
16. Caplan A.I., Correa D.J. PDGF in bone formation and regeneration: New insights into a novel mechanism involving MSCs. J Orthop Res. 2011;29(12):1795–1803.
17. Heldin C.H., Westermark B. Platelet-derived growth factor: mechanism of action and possible in vivo function. Cell Regul. 1990;1(8):555–566.
18. Мазуров А.В. Морфология и функции тромбоцитов. М., 2011 [Mazurov A.V. Morphology and functions of thrombocytes. Moscow, 2011 (In Russ.)].
19. White J. EDTA-induced changes in platelet structure. Platelets. 2000;11(1):49–55.
20. Delgado J.J., Sánchez E., Baro M., Reyes R., Evora C., Delgado A. A platelet derived growth factor delivery system for bone regeneration. J Mater Sci Mater Med. 2012;29(8):1903–1912.
21. Li J., Wei Y., Liu K., Yuan C., Tang Y., Quan Q., Chen P., Wang W., Hu H., Yang L. Synergistic effects of FGF-2 and PDGF-BB on angiogenesis and muscle regeneration in rabbit hindlimb ischemia model. Microvasc Res. 2010;80(1):10–17.
22. Кузнецова О.М., Кушлинский Н.Е., Березов Т.Т. Фактор роста эндотелия сосудов: особенности секреции в костной ткани в норме и при патологии. Биомедицинская химия. 2003;49(4):360–373 [Kuznetsova O.M., Kushlinskiy N.E., Berezov T.T. Factor of vascular endothelial growth: features of secretion in bone tissue in normal and pathological conditions. Biomedical Chemistry = Biomedicinskaya himiya. 2003;49(4):360–373 (In Russ.)].
23. Факторы роста. Журнал БиоХимМак. 39:392–400 [Growth Factors. BioChemMak magazine. 39:392–400 (In Russ.)]. https://biochemmack.ru/upload/uf/d34/d34c859be8554012638d04aad2b67344.pdf
24. Paques M., Chastang C., Mathis A., Sahel J., Massin P., Dosquet C., Korobelnik J.F., Le Gargasson J.F., Gaudric A. Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicenter, double-masked, randomized trial. Platelets in Macular Hole Surgery Group. Ophthalmology. 1999 May;106(5):932–938.
25. Blumenkranz M.S., Ohana E., Shaikh S., Chang S., Coll G., Morse L.S., De Bustros S. Adjuvant methods in macular hole surgery: intraoperative plasma-thrombin mixture and postoperative fluid-gas exchange. Ophtalmic Surg Lasers. 2001;32(3):198–207.
26. Konstantinidis A., Hero M., Nanos P., Panos G.D. Efficacy of autologous platelcts in macular hole surgery. Clin Ophthalmol. 2013;7:745–750. DOI: 10.2147/OPTHS44440
27. Alio J.L., Arnalich-Montiel F., Rodriguez A.E. The role of “eye platelet rich plasma” (E-PRP) for wound healing in ophthalmology. Curr Pharm Biotechnol. 2012 Jun;13(7):1257–1265.
28. Лошкарева А.О., Майчук Д.Ю. Применение богатой тромбоцитами плазмы у пациентов с хроническими эрозиями роговицы. Современные технологии в офтальмологии. 2016;4:131–132 [Loshkareva A.O., Maychuk D.Yu. Use of Platelet-rich Plasma in Patients with Chronic Corneal Erosions. Modern Technologies in Ophthalmology = Sovremennye tekhnologii v oftal’mologii. 2016;4:131–132 (In Russ.)].
29. Jun Hun Lee, Myung Jun Kim, Sang Won Ha, Hong Kyun Kim. Autologous Plateletrich Plasma Eye Drops in the Treatment of Recurrent Corneal Erosions. Korean J Ophthalmol. 2016 Apr;30(2):101–107.
Review
For citations:
Fedoseeva E.V., Chentsova E.V., Borovkova N.V., Alekseeva I.B., Romanova I.Yu. Morphofunctional Peculiarities of Platelet Rich Plasma and Its Application in Ophthalmology. Ophthalmology in Russia. 2018;15(4):388-393. (In Russ.) https://doi.org/10.18008/1816-5095-2018-4-388-393
Views:
1719
Email this article 